• 제목/요약/키워드: total-cholesterol

검색결과 4,714건 처리시간 0.035초

축제식양식장에서 사육한 돌돔, Oplegnathus fasciatus의 백점충, Crytocaryon irritans 감염 특성 (Characteristics on the Crytocaryon irritans of Rock bream, Oplegnathus fasciatus in the embankment fish farm)

  • 최혜승;방종득;박명애
    • 한국어병학회지
    • /
    • 제23권3호
    • /
    • pp.281-291
    • /
    • 2010
  • 2009년 7~12월, 축제식 양식장에서 돌돔의 백점충 감염 조사결과, 감염률은 20.0~88.0%로 9월이 높았고 7월이 낮았다. 7, 8월에는 죽는 개체가 없었으나 9월 중순 이후에는 폐사가 발생하였다. 수온 $19.3{\sim}24.3^{\circ}C$, 용존산소 5.0~7.1 mg/L, pH 8.0~8.1, 염분 31.9~33.7psu로 폐사 발생시의 수온은 약 $24.0^{\circ}C$ 였다. 백점충 감염초기의 외부증상으로는 돌돔의 활력은 양호하였으나 체표에 점액분비로 번들거림을 확인 수 있었으며, 대량폐사가 발생한 시기인 10월에는 점액분비 과다, 꼬리지느러미 탈락 및 발적, 체표 출혈반점과 안구충혈 증상을 보였으며 유영력이 매우 저하되어 있었다. 내부증상으로 간, 장 충혈 및 비장비대 증상을 나타내었다. 백점충은 아가미의 호흡상피 아래 조직 내에 매몰되어 기생기와 자유유영기 상태였음을 확인하였다. 백점충은 7월경에 감염되어 수온 상승과 함께 사료급이량 증가와 돌돔의 빠른 성장이 백점충 증식의 호조건 조성으로 폐사가 더욱 가중된 것으로 추정되었다. 조사기간 중 간중량지수 (HSI)는 $1.9{\pm}1.1{\sim}3.5{\pm}1.7$ %로 폐사발생기인 9월에 가장 낮았으며, 11월에 가장 높았다. 백점충에 감염된 돌돔 혈액의 헤마토크릿트 값은 7, 8월에 각각 37.3%, 41.0%, 9, 10월에 각각 32.14%, 24.17%로 차이를 보였다. 총콜레스테롤, 중성지방은 7, 8월에 비해 10월에 급격한 저하를 보였고, 폐사 발생후 AST는 약 7배, ALT는 약 5배 높았다.

거정석 첨가 급여가 비육한우의 체중 증가량, 혈액 성상, 면역성 및 도체등급에 미치는 영향 (Effects of Dietary Addition of Pegmatite on Body Weight Gain, Blood Characteristics, and Immunity and Carcass Grade for Fattening Hanwoo)

  • 김병기;하재정;이준구;오동엽;정대진;황은경;최성복
    • 한국식품영양학회지
    • /
    • 제30권4호
    • /
    • pp.703-709
    • /
    • 2017
  • This study analyzed the effect on weight and average daily gain, carcass grade, and blood characteristics and immunity in case of dietary addition of pegmatite to Hanwoo steers. Relative to Hanwoo steers, initial body weight was $257.3{\pm}11.74kg$ (8-months old after birth). Forty-eight Hanwoo steers were fed for 24 months using random arrangement (4 treatment plots${\times}$4 heads${\times}$3 repeat). The treatment plot (498.75~500.82 kg) had higher weight during the early fattening stage compared with that of the control plot (474.37 kg) (p<0.05). Regarding total cholesterol of the blood, the value was similar to one during initiation of testing, but the value increased gradually based on the progress of fattening. In addition, the triglyceride was considerably low in T2~T3 plots with high addition of pegmatite during the late fattening stage compared with other treatment plots (p<0.05). This study revealed a tendency in the IgG content that represented immunity as the addition of pegmatite became higher (p>0.05). This study found that the treatment plot (441.55~452.10 kg) had higher carcass weight compared with the control plot (436.30 kg). However, this study revealed that the treatment plot (2.30~2.55 points) had higher carcass quantity grade compared with the control plot (2.11 points). This study found that the control plot (3.55 points) had higher carcass quality grade compared with the treatment plot (2.67~3.09 points) (p>0.05). With studies combined, it was determined that dietary addition of pegmatite to the feed as clay minerals in fattening Hanwoo steers would improve feed intake, body weight gain and carcass quantity grade.

닭에서의 지방산(脂肪酸) 생합성(生合成)에 미치는 급여지방산(給與脂肪酸)의 영향(影響) (Fatty Acid Biosynthesis of Chicken Fed Various Long Chain Fatty Acids)

  • 고태송
    • 한국식품과학회지
    • /
    • 제10권3호
    • /
    • pp.313-319
    • /
    • 1978
  • 무지방사료(無脂肪飼料) 및 여기에 17:0, 18:0 혹은 18:2을 첨가(添加)한 사료(飼料)를 병아리에 급여(給與)해서 간장(肝臟) 및 혈장(血漿)의 각지질분획(各脂質分劃)의 지방산조성(脂肪酸組成)에 미치는 급여지방산(給與脂肪酸)의 영향(影響)을 조사(調査)하였다. 그 결과(結果) 간장중(肝臟中)의 총지질함량(總脂質含量) 및 각지질분획(各脂質分劃)의 함량(含量)은 급여지방산(給與脂肪酸)에 의해서 영향(影響)받지 않았다. 그러나 17:0을 급여(給與)하면 간장(肝臟) 및 혈장(血漿)의 각지질분획(各脂質分劃)에 17:0 및 17:1 출현(出現)하고, 혈장(血漿)트리그리세라이드에서는 17:0이 또한 혈장(血漿)콜레스테롤에스텔에서는 17:1이 다른 분획(分劃)보다도 유의(有意)하게 높았다. 더욱이 간장(肝臟)에서는 각분획(各分劃)사이에 양지방산(兩脂肪酸)의 분포치(分布値)에 큰 차이(差異)가 없었다. 18:2의 급여(給與)도 17:0을 급여(給與)한때와 같이 간장(肝臟) 및 혈장(血漿)의 각지질분획(各脂質分劃)에 18:2이 출현(出現)하고, 특(特)히 간장인지질분획(肝臟燐脂質分劃)에서 18:2의 분포치(分布値)는 다른분획(分劃)보다도 유의(有意)하게 높았다. 그러나 18:0을 급여(給與)해도 이것이 간장(肝臟) 및 혈장중(血漿中)에 특별적(特別的)으로 증가(增加)하지는 않았다. 또한 17:0 및 18:2과 같은 외인성지방산(外因性脂肪酸)의 급여(給與)에 의하여 내인적(內因的)으로 합성(合成)되는 16:1 및 18:1의 분포치(分布値)는 간장(肝臟)에서 감소(減少)하는 경향(傾向)을 나타내었다.

  • PDF

오디, 뽕잎 및 누에의 혼합비율에 따른 Streptozotocin 유발 당뇨쥐에서의 항산화 효과 및 지질대사개선 효과 (Antioxidant Effects and Improvement of Lipid Metabolism of Mulberry fruit, Mulberry Leaves and Silkworm Powder with Different Mixing Ratios in Streptozotocin-Induced Diabetic Rats)

  • 권은혜;정명애;이순재;최상원;조성희
    • Journal of Nutrition and Health
    • /
    • 제39권2호
    • /
    • pp.91-99
    • /
    • 2006
  • This study was conducted to investigate the effects of mulberry fruit, mulberry leaves and silkworm powder with different mixing ratios on hepatic antioxidative system and lipid metabolism in streptozotocin-induced diabetic rats. Sprague-Dawley male rats weighing $100{\pm}10g$ were induced diabetic by 50 mg/kg bw streptozotocin and randomly assigned to following experimental groups; normal diet group (DM), 0.3% and 0.6% mulberry fruit diet groups (F and 2F), 0.3% mulberry leaves diet group (M), 0.3% silkworm powder diet group (S), 0.15% mulberry fruit+0.15% mulberry leaves diet group (FM), 0.15% mulberry fruit+0.15% silkworm powder diet group (FS), 0.1 % mulberry fruit+0.1 % mulberry leaves+0.1% silkworm powder diet group (FMS). The experimental diets were fed for 4 weeks. Hepatic SOD activity was not changed significantly by any of single or combined supplementations of mulberry fruit, leaves and silkworm powder but GSH-px and catalase activities were increased by the groups supplemented with two or three of the test ingredients (FM, FS, FMS) as compared with the DM group. Hepatic TBARS value was not reduced significantly by any of the supplementations but lipofuscin contents were significantly reduced in the FM, FS and FMS groups as compared with the DM group. Hepatic mitochondria and microsomal carbonyl values were reduced by the single and combined supplementations of the test ingredients. Hepatic HMG-CoA reductase activities were increased in the all supplementation groups as compared with the DM group. Hepatic total lipid and triglyceride contents were increased but cholesterol contents reduced in the supplemented groups. The effects on the enzyme activities, peroxide or its products and lipid contents were most remarkable in the FMS group. In conclusion, mulberry fruit, mulberry leaves and silkworm powder have the favorable effects on antioxidative system and lipid metabolism in the diabetic liver and the mulberry fruit, leaves and silkworm powder with equal ratio exert the synergistic effect expectedly to prevent diabetic complications.

Low consumption of fruits and dairy foods is associated with metabolic syndrome in Korean adults from outpatient clinics in and near Seoul

  • Song, SuJin;Kim, Eun-Kyung;Hong, Soyoung;Shin, Sangah;Song, YoonJu;Baik, Hyun Wook;Joung, Hyojee;Paik, Hee Young
    • Nutrition Research and Practice
    • /
    • 제9권5호
    • /
    • pp.554-562
    • /
    • 2015
  • BACKGROUND/OBJECTIVES: The aim of this study was to examine differences in nutrient intake and food consumption by the presence of metabolic syndrome in Korean adults. SUBJECTS/METHODS: Study subjects in this cross-sectional study were recruited from four outpatient clinics in and near the Seoul metropolitan area of South Korea between 2006 and 2012. A total of 668 subjects (413 men and 255 women) aged ${\geq}30y$ were included in the final data analyses. For each subject, daily nutrient intake and food consumption were calculated using three days of dietary intake data obtained from a combination of 24-hour recalls and dietary records. To evaluate food consumption, mean number of servings consumed per day and percentages of recommended number of servings for six food groups were calculated. Metabolic syndrome was defined using the National Cholesterol Education Program Adult Treatment Panel III criteria. The general linear model was performed to examine differences in nutrient intake and food consumption by sex and the presence of metabolic syndrome after adjustment for potential confounding variables. RESULTS: Nutrient intake did not differ by the presence of metabolic syndrome in both men and women. Men with metabolic syndrome had lower consumption and percentage of the recommendation for fruits compared with those without metabolic syndrome (1.6 vs. 1.1 servings/day, P-value = 0.001; 63.5 vs. 49.5%, P-value = 0.013). Women with metabolic syndrome showed lower consumption and percentage of the recommendation for dairy foods than those without metabolic syndrome (0.8 vs. 0.5 servings/day, P-value = 0.001; 78.6 vs. 48.9%, P-value = 0.001). CONCLUSIONS: Low intakes of fruits and dairy foods might be associated with the risk of having metabolic syndrome among Korean adults. Dietary advice on increasing consumption of these foods is needed to prevent and attenuate the risk of metabolic syndrome.

실천지침 이행률에 따른 대사증후군 중재 효과 비교: 직장인 남성 대사증후군을 대상으로 (Comparison of health outcomes according to intervention compliance in male Korean workers with metabolic syndrome)

  • 남경희;강지연;이연주;성숙희;장윤균;이지영;박일근;최태인
    • Journal of Nutrition and Health
    • /
    • 제46권2호
    • /
    • pp.156-165
    • /
    • 2013
  • This study examined how achievement of session goals contributes to outcomes of subjects after participation in a 12-week lifestyle intervention program in men with metabolic syndrome (MetS). Thirty office workers with MetS, aged $47.2{\pm}6.6$ years, participated in this study, from March to July, 2011. The intervention program included face-to-face counseling five times during the 12-week period. Counselors and subjects designed session goals for each round. The average of the goal achievement rate was calculated based on compliance for each round. The subjects were divided into three groups according to their tertiles of achievement rate: Low-compliance group (LC, < 59%), medium-compliance group (MC, 59-70%), and high-compliance group (HC, > 70%). Anthropometry, biochemical index, and nutrient intake were examined at baseline and at the end of the 12-week intervention program. After the intervention, diastolic blood pressure (DBP) showed a significant decrease in the LC group, and waist circumference (WC) showed a significant decrease in the MC group. Systolic blood pressure (SBP), DBP, and low-density lipoprotein cholesterol (LDL) showed a significant decrease in the HI group. Changes in SBP and DBP were significantly lower in the HC group than in the MC group (p < 0.05, p < 0.01). Changes in LDL were significantly lower in the HC group than in the MC group (p < 0.05). Results for intake of total energy, protein, fat, and sodium, as well as rates of carbohydrate and fat intake, showed a significant decrease in all participants (p < 0.05). The change in fiber was significantly higher in the HC group than in the MC group (p < 0.05). The change of fruit serving size showed a significant increase in the HC group (p < 0.01). The number of risk factors for MetS showed a significant decrease in the LC and HC groups (p < 0.05), however, no significant mean differences were observed among the three groups. In conclusion, participation in this intervention program resulted in positive effects on risk factors for MetS, nutrient intake, and dietary habits, especially in the High-compliance group.

비만 여성에서 베타-사이클로덱스트린 함유 다이어트 식품의 체중 감소 효과 (The Effect of Antifat Diets with β-Cyclodextrin on the Weight Loss in Obese Korean Women)

  • 박병성
    • 한국식품영양과학회지
    • /
    • 제33권5호
    • /
    • pp.832-838
    • /
    • 2004
  • 본 연구는 성인 비만 여성을 대상으로 45일 동안$\beta$-cyclodextrin을 함유하는 다이어트 식품(antifat diets)의 섭취시 체중, 비만도, 체질량지수, 체지방율, 신체둘레 및 혈액지질수준의 변화를 관찰하였다. Antifat diet섭취 전과 비교하였을 때 antifat diets 섭취 후 체중 3 kg 감소, 비만도 5% 감수 체질량지수 1 kg/$m^2$ 감소, 체지방율 7% 감소가 실제측정치로써 나타났으며, 이를 감소율로써 나타냈을 때 체중 4%, 비만도 13%, 체질량지수 4%, 체지방율 20%의 감소효과가 있었으며 통계적 유의성이 있었다(p<0.05). Antifat diets섭취 전과 비교하였을 때 antifat diets 섭취 후 상위 팔둘레 3 cm 감소, 허리둘레 3 cm 감소, 엉덩이 둘레 3 cm 감소 및 허벅지 둘레 3 cm가 실제 측정치로서 감소하였고, 이를 감소율로써 나타냈을 때 상위팔둘레 8%, 허리둘레 3.4%, 엉덩이둘레 3% 및 허벅지둘레 5%의 감소효과를 보였으며 통계적으로 유의성이 있었다(p<0.05). Antifat diets를 45일간 섭취하였을 경우 antifat diets 섭취 전에 비하여 중성지방 103 mg/dL감소, 총콜레스테롤 50 mg/dL 감소, LDL-C 50 mg/dL 감소가 실제 측정치로써 나타났으며, 이를 감소율로서 나타냈을 때 중성 지 방 40%, 총콜레스테롤 24%, LDL-C 37% 및 동맥경화지수 31%까지 유의적으로 감소하였다(p<0.05). 따라서 $\beta$-cyclodextrin이 비만방지 및 과체중 조절을 위한 새로운 다이어트 식음소재로서 충분히 활용될 수 있음을 알 수 있었다.

육성기 및 비육기에 급여한 감귤 부산물이 제주도 개량 흑돼지 고기의 품질특성에 미치는 영향 (Feeding Effect of Citrus Byproduct on the Quality of Cross-bred Black Pig in Jeju Island)

  • 양승주;고석민;양태익;정인철;문윤희
    • 한국식품영양과학회지
    • /
    • 제35권7호
    • /
    • pp.897-902
    • /
    • 2006
  • 본 연구는 제주도에서 폐기되고 있는 밀감 부산물을 돼지에게 급여하여 페기물의 이용과 기능성 돈육의 생산을 위하여 실시하였다. 돼지는 밀감 부산물을 급여하지 않은 등심육(TB-0) 및 육성기에 6% 급여한 후 비육기에 10% 급여한 등심육(TB-1)을 대상으로 여러 가지 영양성분 분석과 관능검사를 실시한 결과 수분, 조단백질, 조지방, 조회분 및 열량은 시료들 사이에 차이가 없었다. 콜레스테롤 함량은 TB-1(41.5 mg/100g)이 TB-0)48.9 mg/100 g)보다 유의하게 낮았다. 무기질 중에서 Mg은 TB-0(192 ppm)가 TB-1(161 ppm)보다 유의하게 높았으며, 비타민 $B_1$$B_2$는 시료들 사이에서 차이가 없었다. 총아미노산 함량은 TB-0 및 TB-1이 각각 19.51 및 18.65%이고, 총유리아미노산 함량은 각각 469.44 및 479.45 mg/100 g으로 처리구간에 유의한 차이가 없었다. 포화지방산은 palmitic acid가 가장 많았고, 불포화지방산은 oleic acid가 가장 많았다. 생육과 가열육의 맛, 조직감, 다즙성 및 전체적인 기호성은 밀감 부산물 급여에 의한 영향은 없었으며, 풍미는 TB-1이 TB-0보다 유의하게 높았다.

담즙정체성 간염의 임상적 양상 (Clinical Features of Cholestatic Hepatitis)

  • 최선택;은종렬;임상우;김봉준;이헌주;구미진;최준혁
    • Journal of Yeungnam Medical Science
    • /
    • 제18권1호
    • /
    • pp.51-58
    • /
    • 2001
  • 담즙정체성 간염의 원인과 임상양상, 검사실 소견 및 경과를 알아보고자 1991년에서 2000년까지 영남대학교 의과대학 부속병원에서 혈액검사 및 간생검으로 담즙정체성 간염이 확진된 14명의 환자를 대상으로 후향적 연구를 시행하여 다음과 같은 결과를 얻었다. 담즙정체성 간염에서 비정상 간기능검사의 기간은 1개월에서 30개월까지 다양하게 나타났고, 항결핵제, 항생제에 의한 담즙정체성 간염이외에도 한약제, 건강식품에 의한 경우 검사실 소견과 임상경과가 중하게 나타나는 경우가 있으므로, 이들 약물을 사용한 병력이 있는 경우 정기적인 간기능 검사가 필요하다. 담즙정체성 간염이 만성 간내 담즙정체를 보이는 경우 바이러스에 의한 담즙정체성 간염과 담관소멸 증후군으로의 진행 유무, 원발성 담즙성 간경변증, 자가면역성 간염과의 감별이 필요하며, 지속적인 간기능 검사이상을 보일 경우에는 연속적인 간생검이 필요할 것으로 생각된다.

  • PDF

Effect of coadministration of enriched Korean Red Ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A randomized controlled trial

  • Jovanovski, Elena;Smircic-Duvnjak, Lea;Komishon, Allison;Au-Yeung, Fei (Rodney);Sievenpiper, John L.;Zurbau, Andreea;Jenkins, Alexandra L.;Sung, Mi-Kyung;Josse, Robert;Li, Dandan;Vuksan, Vladimir
    • Journal of Ginseng Research
    • /
    • 제45권5호
    • /
    • pp.546-554
    • /
    • 2021
  • Background: Diabetes mellitus and hypertension often occur together, amplifying cardiovascular disease (CVD) risk and emphasizing the need for a multitargeted treatment approach. American ginseng (AG) and Korean Red Ginseng (KRG) species could improve glycemic control via complementary mechanisms. Additionally, a KRG-inherent component, ginsenoside Rg3, may moderate blood pressure (BP). Our objective was to investigate the therapeutic potential of coadministration of Rg3-enriched Korean Red Ginseng (Rg3-KRG) and AG, added to standard of care therapy, in the management of hypertension and cardiometabolic risk factors in type-2 diabetes. Methods: Within a randomized controlled, parallel design of 80 participants with type-2 diabetes (HbA1c: 6.5-8%) and hypertension (systolic BP: 140-160 mmHg or treated), supplementation with either 2.25 g/day of combined Rg3-KRG + AG or wheat-bran control was assessed over a 12-wk intervention period. The primary endpoint was ambulatory 24-h systolic BP. Additional endpoints included further hemodynamic assessment, glycemic control, plasma lipids and safety monitoring. Results: Combined ginseng intervention generated a mean ± SE decrease in primary endpoint of 24-h systolic BP (-3.98 ± 2.0 mmHg, p = 0.04). Additionally, there was a greater reduction in HbA1c (-0.35 ± 0.1% [-3.8 ± 1.1 mmol/mol], p = 0.02), and change in blood lipids: total cholesterol (-0.50 ± 0.2 mmol/l, p = 0.01), non-HDL-C (-0.54 ± 0.2 mmol/l, p = 0.01), triglycerides (-0.40 ± 0.2 mmol/l, p = 0.02) and LDL-C (-0.35 ± 0.2 mmol/l, p = 0.06) at 12 wks, relative to control. No adverse safety outcomes were observed. Conclusion: Coadministration of Rg3-KRG + AG is an effective addon for improving BP along with attaining favorable cardiometabolic outcomes in individuals with type 2 diabetes. Ginseng derivatives may offer clinical utility when included in the polypharmacy and lifestyle treatment of diabetes. Clinical trial registration: Clinicaltrials.gov identifier, NCT01578837;